Home/Filings/4/0001127602-10-028378
4//SEC Filing

HERBERT GAVIN S 4

Accession 0001127602-10-028378

CIK 0000850693other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:42 PM ET

Size

21.2 KB

Accession

0001127602-10-028378

Insider Transaction Report

Form 4
Period: 2010-11-16
Transactions
  • Exercise/Conversion

    Common Stock

    2010-11-16$36.49/sh+5,000$182,45029,400 total
  • Exercise/Conversion

    Common Stock

    2010-11-16$36.85/sh+5,000$184,25019,400 total
  • Gift

    Common Stock

    2010-11-1815,00014,400 total
  • Exercise/Conversion

    Nonemployee Director Stock Option (Right to Buy)

    2010-11-165,0000 total
    Exercise: $36.85From: 2004-04-25Exp: 2013-04-24Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2010-11-16$45.88/sh+5,000$229,42524,400 total
  • Gift

    Common Stock

    2010-11-18+15,000191,960 total(indirect: By Trust)
  • Exercise/Conversion

    Nonemployee Director Stock Option (Right to Buy)

    2010-11-165,0000 total
    Exercise: $45.88From: 2005-04-28Exp: 2014-04-28Common Stock (5,000 underlying)
  • Exercise/Conversion

    Nonemployee Director Stock Option (Right to Buy)

    2010-11-165,0000 total
    Exercise: $36.49From: 2006-04-26Exp: 2015-04-26Common Stock (5,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    3,000
  • Common Stock

    (indirect: By Trust)
    5,000
  • Common Stock

    (indirect: By Trust)
    40,000
  • Common Stock

    (indirect: By Spouse)
    400
Footnotes (7)
  • [F1]Shares held by the Herbert Family Trust. Reporting person is trustee and beneficiary of this trust and has the power to revoke without another's consent.
  • [F2]Shares held by Gavin S. Herbert Trust. The reporting person is beneficiary of this trust.
  • [F3]Shares held by G. Herbert, Inc., which in turn is wholly owned by Gavin Herbert Successor Trust (GHST). The reporting person is co-trustee and has a pecuniary interest in GHST.
  • [F4]Shares held by Ninetta Herbert Living Trust. The reporting person's spouse is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for the purposes of Section 16 or for any other purposes.
  • [F5]The per share exercise price is the closing price of the Common Stock as of April 27, 2004, rounded upwards to three decimals.
  • [F6]Option is fully vested and exercisable on the one year (1) year anniversary of its grant.
  • [F7]The per share exercise price is the closing price of Allergan common stock as of April 25, 2005, rounded upwards to three decimals.

Issuer

ALLERGAN INC

CIK 0000850693

Entity typeother

Related Parties

1
  • filerCIK 0001016361

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:42 PM ET
Size
21.2 KB